Member Login
|
Site Map
|
Disclaimer
|
Contact
|
Bookmark
Advanced Search
Text Size
|
Friday, September 10, 2010
Home
Home
>
Neura
>
Archives
>
Parents, Pesticides, and Proteins: Pathogenetic Mechanisms of Parkinson’s Disease
>
Parents, Pesticides,and Proteins: Pathogenetic Mechanisms of Parkinson’s Disease
>
References
References
1. Thomas B, Beal MF. Parkinson’s disease.
Hum Mol Genet
. 2007;16:183-194. [
PubMed
]
2. Moore DJ, West AB, Dawson VL, Dawson TM. Molecular pathophysiology of Parkinson’s disease.
Annu Rev Neurosci
. 2005;28:57-87. [
PubMed
]
3. Przedborski S. Pathogenesis of nigral cell death in Parkinson’s disease.
Parkinsonism Relat Disord
. 2005;11(suppl 1):3-7. [
PubMed
]
4. Olanow CW, McNaught KS. Ubiquitin-proteasome system and Parkinson’s disease.
Mov Disord
. 2006;21:1806-1823. [
PubMed
]
5. Reinstein E, Ciechanover A. Narrative review: protein degradation and human diseases: the ubiquitin connection.
Ann Intern Med
. 2006;145:676-684. [
PubMed
]
6. Pan T, Kondo S, Le W, Jankovic J. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson’s disease.
Brain
. Jan 10, 2008; e-pub ahead of print. [
PubMed
]
7. Finkbeiner S, Cuervo AM, Morimoto RI, Muchowski PJ. Disease-modifying pathways in neurodegeneration.
J Neurosci
. 2006;26:10349-10357. [
PubMed
]
8. Giasson BI, Lee VM. Are ubiquitination pathways central to Parkinson’s disease?
Cell
. 2003;114:-8. [
PubMed
]
9. Lim KL. Ubiquitin-proteasome system dysfunction in Parkinson’s disease: current evidence and controversies.
Expert Rev Proteomics
. 2007;4:769-781. [
PubMed
]
10. Leroy E, Boyer R, Polymeropoulos MH. Intron-exon structure of ubiquitin c-terminal hydrolase-L1.
DNA Res
. 1998;5:397-400. [
PubMed
]
11. McNaught KS, Björklund LM, Belizaire R, Isacson O, Jenner P, Olanow CW. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.
NeuroReport
. 2002;13:1437-1441. [
PubMed
]
12. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT, Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson’s disease susceptibility.
Cell
. 2002;111:-209-218. [
PubMed
]
13. Beal F, Lang A. The proteasomal inhibition model of Parkinson’s disease: “Boon or bust?”
Ann Neurol
. 2006;60:158-161. [
PubMed
]
14. Norris EH, Giasson BI, Lee VM. Alpha-synuclein: normal function and role in neurodegenerative diseases.
Curr Top Dev Biol
. 2004;60:17-54. [
PubMed
]
15. Cabin DE, Shimazu K, Murphy D, et al. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein.
J Neurosci
. 2002;22:8797-8807. [
PubMed
]
16. McNaught KS, Olanow CW. Protein aggregation in the pathogenesis of familial and sporadic Parkinson’s disease.
Neurobiol Aging
. 2006;27:530-545. [
PubMed
]
17. Norris EH, Giasson BI, Ischiropoulos H, Lee VM. Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications.
J Biol Chem
. 2003;278:27230-27240. [
PubMed
]
18. Conway KA, Harper JD, Lansbury PT. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Nat Med
. 1998;4:1318-1320. [
PubMed
]
19. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
Science
. 2004;305:1292-1295. [
PubMed
]
20. Martinez-Vicente M, Talloczy Z, Kaushik S, et al. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
J Clin Invest
. 2008; 118:777-788. [
PubMed
]
21. Cooper AA, Gitler AD, Cashikar A, et al. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models.
Science
. 2006;313:324-328. [
PubMed
]
22. Dauer W, Kholodilov N, Vila M, et al. Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP.
Proc Natl Acad Sci USA
. 2002;99:14524-14529. [
PubMed
]
23. Barzilai A, Melamed E. Molecular mechanisms of selective dopaminergic neuronal death in Parkinson’s disease.
Trends Mol Med
. 2003;9:126-132. [
PubMed
]
24. Di Monte DA, Lavasani M, Manning-Bog AB. Environmental factors in Parkinson’s disease.
Neurotoxicology
. 2002;23:487-502. [
PubMed
]
25. Brown TP, Rumsby PC, Capleton AC, Rushton L, Levy LS. Pesticides and Parkinson’s disease––is there a link?
Environ Health Perspect
. 2006;114:156-164. [
PubMed
]
26. Calne DB, Langston JW. Aetiology of Parkinson’s disease.
Lancet
. 1983;2:1457-1459. [
PubMed
]
27. Barlow BK, Cory-Slechta DA, Richfield EK, Thiruchelvam M. The gestational environment and Parkinson’s disease: evidence for neurodevelopmental origins of a neurodegenerative disorder.
Reprod Toxicol
. 2007;23: 457-470. [
PubMed
]
28. Ling Z, Gayle DA, Ma SY, et al. In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.
Mov Disord
. 2002;17:116-124. [
PubMed
]
29. Ling ZD, Chang Q, Lipton JW, Tong CW, Landers TM, Carvey PM. Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain.
Neuroscience
. 2004;124:619-628. [
PubMed
]
30. Barlow BK, Richfield EK, Cory-Slechta DA, Thiruchelvam M. A fetal risk factor for Parkinson’s disease.
Dev Neurosci
. 2004;26:11-23. [
PubMed
]
31. Cory-Slechta DA, Thiruchelvam M, Richfield EK, Barlow BK, Brooks AI. Developmental pesticide exposures and the Parkinson’s disease phenotype.
Birth Defects Res A Clin Mol Teratol
. 2005;73:136 -139. [
PubMed
]
32. Costa LG, Giordano G, Guizzetti M, Vitalone A. Neurotoxicity of pesticides: a brief review.
Front Biosci
. 2008;13:1240-1249. [
PubMed
]
33. Kaur D, Peng J, Chinta SJ, et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age.
Neurobiol Aging
. 2007;28:907-913. [
PubMed
]
34. Betarbet R, Canet-Aviles RM, Sherer TB, et al. Intersecting pathways to neurodegeneration in Parkinson’s disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system.
Neurobiol Dis
. 2006;22:404-420. [
PubMed
]
35. Norris EH, Uryu K, Leight S, Giasson BI, Trojanowski JQ, Lee VM. Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model.
Am J Pathol
. 2007;170:658-666. [
PubMed
]
36. Wood-Kaczmar A, Gandhi S, Wood NW. Understanding the molecular causes of Parkinson's disease.
Trends Mol Med
. 2006;12:521-528. [
PubMed
]
37. Moore DJ, Dawson VL, Dawson TM. Role for the ubiquitin-proteasome system in Parkinson’s disease and other neurodegenerative brain amyloidoses.
Neuromolecular Med
. 2003;4:95-108. [
PubMed
]
Neura.net is administered, managed, and populated by Expert Medical Education, a company dedicated to the education of healthcare professionals. The individual educational materials available here are supported by educational grants from Teva Neuroscience. This site is intended for U.S. audiences only. This Web site is for use by healthcare professionals only. It is not meant to serve as a substitute for a consultation with your physician. If you are a patient and would like to see Neura.net's educational material for patients,
click here
. Some discussions of drugs and devices contained on this Web site may include mention of uses that have not been evaluated by the United States Food and Drug Administration for safety and efficacy. Please consult complete prescribing information for any of the drugs and devices discussed before using them.
© 2010 Neura.net. All rights reserved.
